Application of next generation sequencing technology in personalized medicine of lung cancer / 中华检验医学杂志

ABSTRACT

Lung cancer is the most common malignant tumor in the world and the leading cause of cancer-related deaths. Like other tumors, lung cancer is heterogeneous in the process of tumor development. A comprehensive understanding of heterogeneity can achieve personalized medicine in the true sense, which is the essence of precision medicine. In recent years, nextgeneration sequencing technology has provided novel and important technical means for precision medicine based on its advantages of high-throughput and multi-target analysis. It plays an increasingly important role in molecular typing, targeted drug selection and prognosis prediction of lung cancer.